|
DCP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.841400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.390200E-02 |
| Normal-vs-Stage2 |
1.362390E-01 |
| Normal-vs-Stage3 |
4.300400E-01 |
| Normal-vs-Stage4 |
6.415000E-01 |
| Stage1-vs-Stage2 |
9.624400E-01 |
| Stage1-vs-Stage3 |
4.433200E-01 |
| Stage1-vs-Stage4 |
7.162600E-01 |
| Stage2-vs-Stage3 |
5.915800E-01 |
| Stage2-vs-Stage4 |
7.924400E-01 |
| Stage3-vs-Stage4 |
9.221600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.934500E-02 |
| Normal-vs-AfricanAmerican |
3.580200E-02 |
| Normal-vs-Asian |
3.202300E-03 |
| Caucasian-vs-AfricanAmerican |
7.299000E-01 |
| Caucasian-vs-Asian |
1.256750E-01 |
| AfricanAmerican-vs-Asian |
1.325760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.989700E-02 |
| Normal-vs-Female |
5.342600E-03 |
| Male-vs-Female |
1.476160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.566400E-01 |
| Normal-vs-Extreme_Weight |
5.269700E-02 |
| Normal-vs-Obese |
3.386000E-02 |
| Normal-vs-Extreme_Obese |
9.453800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.894210E-01 |
| Normal_Weight-vs-Obese |
1.351010E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.954600E-01 |
| Extreme_Weight-vs-Obese |
7.886200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.433000E-01 |
| Obese-vs-Extreme_Obese |
2.551400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.481010E-03 |
| Normal-vs-Age(41-60Yrs) |
1.539210E-03 |
| Normal-vs-Age(61-80Yrs) |
1.924960E-01 |
| Normal-vs-Age(81-100Yrs) |
9.970200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.853000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.566300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.747900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.378450E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.179220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.104400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.583310E-03 |
| Normal-VS-Type2 PRCC |
7.461600E-01 |
| Normal-VS-KIRP CIMP |
1.734160E-02 |
| Normal-VS-Unclassified PRCC |
9.443800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.058710E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.852400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.475800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.861900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.722400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.138400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.931800E-01 |
| Normal-vs-N1 |
1.108750E-01 |
| Normal-vs-N2 |
9.056200E-01 |
| N0-vs-N1 |
2.711600E-01 |
| N0-vs-N2 |
7.996400E-01 |
| N1-vs-N2 |
5.185800E-01 |
|
|
